-
Announced28/05/2025
-
Estimated published11/06/2025
-
Today22/06/2025
Utilities
- indicates text translated automatically in your browsing language
Neurostimulation methods for the treatment of focal epilepsies (market research) Text automatically translated in your browsing language Automatically translated
For the purpose of informing the market about a planned procurement, the Saarland University Hospital (UKS) conducts a market survey in accordance with § 28 of the Public Procurement Ordinance. Within one year, the UKS plans to procure 20 systems of direct cortical stimulation for the treatment of focal epilepsy. The purpose of this query is to check and confirm whether Precisis GmbH actually has a unique selling point. The "EASEE" is the only approved neurostimulation method in Europe for the treatment of focal epilepsy. If this request applies to your company's product, please express your interest no later than 11/06/2025, 12 noon, to the following e-mail address: vergabestelle@uks.eu Text automatically translated in your browsing language Automatically translated
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.